- Added on November 11 2023
- https://chat.openai.com/g/g-RHnoLOeCd-azalea-timi-71
How to use AZALEA-TIMI 71?
-
Step 1 ： Click the open gpts about AZALEA-TIMI 71 button above, or the link below.
-
Step 2 ： Follow some prompt about AZALEA-TIMI 71 words that pop up, and then operate.
-
Step 3 ： You can feed some about AZALEA-TIMI 71 data to better serve your project.
-
Step 4 ： Finally retrieve similar questions and answers based on the provided content.
FAQ from AZALEA-TIMI 71?
The AZALEA-TIMI 71 trial is a randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of AZD9773, an investigational treatment for sepsis. The primary objective of the trial is to assess the effect of AZD9773 on 28-day all-cause mortality in patients with sepsis.
The inclusion criteria for the AZALEA-TIMI 71 trial include patients aged 18 years or older who meet the diagnostic criteria for sepsis and have at least two systemic inflammatory response syndrome (SIRS) criteria. Patients must also have evidence of infection and either be receiving or have received antibiotics within the past 24 hours.
The secondary outcomes of the AZALEA-TIMI 71 trial include the effect of AZD9773 on organ dysfunction, the duration of mechanical ventilation and vasopressor use, and 90-day all-cause mortality. The trial will also evaluate the impact of AZD9773 on long-term quality of life and cost-effectiveness.